- Abstract
- Core Tip
- Article Highlights
- Full Article (PDF)
- Full Article with Cover (PDF)
- Full Article (XML)
- Full Article (HTML)
- Audio
- PubMed Central
- PubMed
- CrossRef
- Google Scholar
- Similar Articles (1004)
- Timeline of Article Publication (1)
- Authors Evaluation (1)
- Article Quality Tracking (1)
- Reference Citation Analysis (0)
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3071)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2023 (publication date) through Jun 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | He K, Xie CZ, Li Y, Chen ZZ, Xu SH, Huang SQ, Yang JG, Wei ZQ, Peng XD. Dopamine and cyclic adenosine monophosphate-regulated phosphoprotein with an apparent Mr of 32000 promotes colorectal cancer growth. World J Gastrointest Oncol 2023; 15(11): 1936-1950 [PMID: 38077650 DOI: 10.4251/wjgo.v15.i11.1936] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i11/1936.htm |
| Number | Citing Articles |
| 1 |
Zhibin Zeng, Shirong Cai, Chenle Ye, Tongduan Li, Yan Tian, Enyuan Liu, Junbin Cai, Xiaojun Yuan, Heng Yang, Quanqi Liang, Kaishu Li, Cui Peng. Neural influences in colorectal cancer progression and therapeutic strategies. International Journal of Colorectal Disease 2025; 40(1) doi: 10.1007/s00384-025-04887-w
|
| 2 |
Sang Hoon Joo, Kyung-Soo Chun. Therapeutic strategies for colorectal cancer: antitumor efficacy of dopamine D2 receptor antagonists. Toxicological Research 2024; 40(4): 533 doi: 10.1007/s43188-024-00259-8
|